Skip to main content
SpringerLink
Log in

Drug interactions between drugs recommended in NICE guidelines

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. atrial fibrillation, chronic kidney disease, chronic obstructive pulmonary disease, dementia, hypertension, neuropathic pain, osteoarthritis, rheumatoid arthritis, and secondary prevention after myocardial infarction

References

  1. Dumbreck S, et al. Drug-disease and drug-drug interactions: systematic examination of recommendations in 12 UK national clinical guidelines. BMJ 2015: h949, No. 350, 11 Mar 2015. Available from: URL: http://dx.doi.org/10.1136/bmj.h949

  2. Marengoni A, et al. Guidelines, polypharmacy, and drug-drug interactions in patients with multimorbidity. BMJ 2015: h1059, No. 350, 11 Mar 2015. Available from: URL: http://dx.doi.org/10.1136/bmj.h1059

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Drug interactions between drugs recommended in NICE guidelines. Reactions Weekly 1543, 12 (2015). https://doi.org/10.1007/s40278-015-8636-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-015-8636-y

Search

Navigation